ESETT - The Established Status Epilepticus Treatment Trial 

Registered with NCT01960075

NIH Project Number: 1U01NS088034-01

Status: Enrollment Closed

The Established Status Epilepticus Treatment Trial (ESETT) is a multicenter, randomized, double-blind, comparative effectiveness study of fos-phenytoin, levetiracetam, and valproic acid in subjects with benzodiazepine-refractory status epilepticus. Patients will be recruited by two national emergency research networks:  Neurology Emergency Treatment Trials (NETT) network and Pediatric Emergency Care and Applied Research Network (PECARN).  Each network has successfully undertaken a Status Epilepticus treatment trial under exception from informed consent (EFIC) rules. For more information on ESETT click on the Synopsis.

Findings: Click on the NEJM and Lancet icons below to read the ESETT published articles.